Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

Background Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical features, management and outcomes for patients treated with intravenou...

Full description

Bibliographic Details
Main Authors: Lei Zheng, Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, Cheng Ting Lin, Peter B Illei, Sonye K Danoff, Karthik Suresh, Christine Hann, Aanika Balaji, Melinda Hsu, Josephine Feliciano, Kristen Marrone, Valerie Lee
Format: Article
Language:English
Published: BMJ Publishing Group 2021-01-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/1/e001731.full

Internet

https://jitc.bmj.com/content/9/1/e001731.full

Similar Items